| Product Code: ETC10765621 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Latvia saw significant import shipments of pemetrexed from top exporting countries such as Lithuania, Netherlands, Switzerland, Poland, and Germany. Despite the diverse sources of imports, market concentration, as measured by HHI, remained low in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 8.6%, indicating a strong and consistent growth trend. Furthermore, the growth rate from 2023 to 2024 was recorded at 7.03%, highlighting a positive trajectory for the import market of pemetrexed in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Pemetrexed Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Pemetrexed Market - Industry Life Cycle |
3.4 Latvia Pemetrexed Market - Porter's Five Forces |
3.5 Latvia Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Latvia Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Latvia Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Latvia Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Latvia Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Latvia Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latvia Pemetrexed Market Trends |
6 Latvia Pemetrexed Market, By Types |
6.1 Latvia Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Latvia Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Latvia Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Latvia Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Latvia Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Latvia Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Latvia Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Latvia Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Latvia Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Latvia Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Latvia Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Latvia Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Latvia Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Latvia Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Latvia Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Latvia Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Latvia Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Latvia Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Latvia Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Latvia Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Latvia Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Latvia Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Latvia Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Latvia Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Latvia Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Latvia Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Latvia Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Latvia Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Latvia Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Latvia Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Latvia Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Latvia Pemetrexed Market Import-Export Trade Statistics |
7.1 Latvia Pemetrexed Market Export to Major Countries |
7.2 Latvia Pemetrexed Market Imports from Major Countries |
8 Latvia Pemetrexed Market Key Performance Indicators |
9 Latvia Pemetrexed Market - Opportunity Assessment |
9.1 Latvia Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Latvia Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Latvia Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Latvia Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Latvia Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Latvia Pemetrexed Market - Competitive Landscape |
10.1 Latvia Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Latvia Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here